Arterra Bioscience S.p.A. (BIT:ARBS)
2.840
+0.010 (0.35%)
Jun 15, 2026, 5:54 PM CET
Arterra Bioscience Revenue
In the year 2025, Arterra Bioscience had annual revenue of 4.70M EUR with 12.74% growth. Arterra Bioscience had revenue of 1.61M in the half year ending December 31, 2024, with 49.29% growth.
Revenue
4.70M
Revenue Growth
+34.80%
P/S Ratio
4.02
Revenue / Employee
130.69K
Employees
36
Market Cap
18.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.70M | 531.61K | 12.74% |
| Dec 31, 2024 | 4.17M | 836.81K | 25.08% |
| Dec 31, 2023 | 3.34M | -254.87K | -7.10% |
| Dec 31, 2022 | 3.59M | -1.15M | -24.27% |
| Dec 31, 2021 | 4.74M | 569.11K | 13.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 2.65B |
| Amplifon | 2.39B |
| DiaSorin | 1.17B |
| EL.En. | 594.84M |
| GPI S.p.A. | 546.18M |
| Svas Biosana | 141.56M |
| Talea Group | 132.17M |
| Farmacosmo | 56.13M |
Arterra Bioscience News
- 6 weeks ago - Arterra Bioscience Earnings release: Q1 2026 - Filings
- 2 months ago - Arterra Bioscience Earnings release: H2 2025 - Filings
- 4 months ago - Arterra Bioscience Earnings release: Q4 2025 - Filings
- 7 months ago - Arterra Bioscience Earnings release: Q3 2025 - Filings
- 9 months ago - Arterra Bioscience Earnings release: H1 2025 - Filings
- 9 months ago - Arterra Bioscience Quarterly report: H1 2025 - Filings
- 11 months ago - Arterra Bioscience Earnings release: Q2 2025 - Filings